SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotech Jim who wrote (7382)1/9/2019 11:17:48 AM
From: scaram(o)uche   of 7424
 
Hey, Jim. I know nothing about the project other than it made for a few good trades, unconfirmed comments from twitter, and text from the PR.

So...... twitter comments from those who posture as knowing about the Otsuka project.... Otsuka efficacy not as pronounced as for the axsm combo. PR text........ modest trial size, toxicity not at all an issue. Not sufficiently tested, for sure. Know nada about tox from Otsuka.

Combination of generics.... sounds good to me! Only things that caught my eye were market cap in context of market size, and PR's wording re. tox. Critical evaluation it wasn't.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext